Simulations Plus, Inc. (NASDAQ:SLP) CEO Walter S. Woltosz sold 18,500 shares of the firm’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $15.78, for a total value of $291,930.00. Following the sale, the chief executive officer now owns 5,610,916 shares in the company, valued at approximately $88,540,254.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Simulations Plus, Inc. (NASDAQ:SLP) traded down $0.05 during trading hours on Monday, reaching $15.90. The company’s stock had a trading volume of 72,667 shares, compared to its average volume of 53,185. Simulations Plus, Inc. has a one year low of $8.81 and a one year high of $17.45. The stock has a market capitalization of $275.69, a price-to-earnings ratio of 46.91 and a beta of -0.76.
Simulations Plus (NASDAQ:SLP) last announced its earnings results on Tuesday, November 14th. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.05 by $0.01. Simulations Plus had a return on equity of 23.95% and a net margin of 23.94%. The business had revenue of $6.30 million for the quarter, compared to analyst estimates of $5.01 million. equities research analysts expect that Simulations Plus, Inc. will post 0.39 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Monday, November 20th. Stockholders of record on Monday, November 13th were given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.51%. This is a positive change from Simulations Plus’s previous quarterly dividend of $0.05. The ex-dividend date of this dividend was Friday, November 10th. Simulations Plus’s payout ratio is presently 72.73%.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. GSA Capital Partners LLP increased its holdings in Simulations Plus by 118.7% in the third quarter. GSA Capital Partners LLP now owns 47,110 shares of the technology company’s stock valued at $730,000 after buying an additional 25,571 shares during the last quarter. OxFORD Asset Management LLP increased its holdings in Simulations Plus by 471.6% in the third quarter. OxFORD Asset Management LLP now owns 58,336 shares of the technology company’s stock valued at $910,000 after buying an additional 48,131 shares during the last quarter. Cadence Capital Management LLC increased its holdings in Simulations Plus by 5.1% in the third quarter. Cadence Capital Management LLC now owns 116,304 shares of the technology company’s stock valued at $1,803,000 after buying an additional 5,636 shares during the last quarter. Macquarie Group Ltd. bought a new stake in Simulations Plus in the third quarter valued at about $315,000. Finally, Russell Investments Group Ltd. bought a new stake in Simulations Plus in the third quarter valued at about $436,000. 33.56% of the stock is currently owned by institutional investors and hedge funds.
SLP has been the topic of a number of research analyst reports. BidaskClub cut Simulations Plus from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. Zacks Investment Research lowered Simulations Plus from a “buy” rating to a “hold” rating in a research report on Wednesday, September 20th.
ILLEGAL ACTIVITY NOTICE: “Simulations Plus, Inc. (NASDAQ:SLP) CEO Walter S. Woltosz Sells 18,500 Shares” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/12/11/simulations-plus-inc-slp-ceo-walter-s-woltosz-sells-18500-shares.html.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.